Scott Phillips named to Genome BC’s I2 Fund Advisory Council

VICTORIA, B.C., May 31, 2016 – StarFish Medical announces Scott Phillips, President and Founder, has been appointed to the Genome BC I2 Fund Advisory Council. Council members are chosen for significant “technology innovator” business experience with BC life science technologies and serve two year terms.

Genome BC’s I2 Fund provides commercialization support for companies developing innovative life science technologies in British Columbia (BC). Life sciences includes the biological aspects of industry challenges in the key economic sectors of Agriculture, Energy and Mining, Environment, Fisheries and Aquaculture, Forestry, and Human Health.

The I2 Fund will also support digital health and other technologies that will further move the concept of precision medicine into clinical practice. The I2 funding is repayable and is allocated to promising technologies (products, processes or services) at the early stages of commercial development. The Fund aims to provide risk capital that is concurrently matched by other public or private funding sources. The I2 Fund Advisory Council held their first meeting on May 19, 2016, in Vancouver BC.

“I’m a firm believer in programs like Genome BC’s I2 Fund that support Life sciences innovation,” says Phillips. “Wise, early investment in organizations and technologies can make a huge impact in building regional critical mass for the growing BC medtech community. I look forward to working with the council to help identify innovations and opportunities that can make a real difference.”

About Genome British Columbia
Genome British Columbia leads genomics innovation on Canada’s West Coast and facilitates the integration of genomics into society. A recognized catalyst for government and industry, Genome BC invests in research, entrepreneurship and commercialization in life sciences to address challenges in key sectors such as health, forestry, fisheries and aquaculture, agri-food, energy, mining and environment. Genome BC partners with many national and international public and private funding organizations to drive BC’s bioeconomy. In addition to research, entrepreneurship and commercialization programs, Genome BC is committed to fostering an understanding and appreciation of the life sciences among teachers, students and the general public.
Genome BC Media Contact: Jennifer Boon | | 778-327-8374 |

About StarFish Medical:
StarFish Medical provides award-winning design, development, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Cardiovascular, Digital Health, IVD, Ophthalmology, Optics, and Ultrasound. StarFish expertise includes electronics, mechanical, human factors and software systems engineering.

Our proprietary Pathfinder™ process for medical device product definition saves clients time and resources throughout the technology and product development phases to commercialization. Prototype and low volume complex electro-mechanical production are delivered in an ISO 13485 certified facility with FDA registration, including cleanroom capabilities.

Regulatory and quality system (QMS) consultants at StarFish provide technical regulatory assistance for FDA and Health Canada submissions, including IEC 60601 and ISO13485.
StarFish Medical Media Contact: Mike Camplin | | 250.388.3531 ext. 210 |

Join over 6000 medical device professionals who receive our engineering, regulatory and commercialization insights and tips every month.